Skip to main content

Methscopolamine Side Effects

Medically reviewed by Drugs.com. Last updated on Oct 25, 2023.

Applies to methscopolamine: oral tablets.

Side effects include:

Xerostomia, decreased sweating, adverse ocular effects (e.g., blurred vision, mydriasis, cycloplegia, increased ocular tension).

For Healthcare Professionals

Applies to methscopolamine: oral tablet.

Cardiovascular

Frequency not reported: Tachycardia, palpitation[Ref]

Hypersensitivity

Frequency not reported: Severe allergic reaction or drug idiosyncrasies including anaphylaxis[Ref]

Nervous system

Frequency not reported: Headaches, drowsiness, dizziness, loss of taste[Ref]

Ocular

Frequency not reported: Blurred vision, dilatation of the pupil, cycloplegia, increased ocular tension[Ref]

Gastrointestinal

Frequency not reported: Nausea, vomiting, constipation, bloated feeling, xerostomia[Ref]

Dermatologic

Frequency not reported: Decreased sweating, urticaria and other dermal manifestations[Ref]

Genitourinary

Frequency not reported: Urinary hesitancy and retention, impotence, suppression of lactation[Ref]

Other

Frequency not reported: Weakness[Ref]

Psychiatric

Frequency not reported: Nervousness, mental confusion, insomnia[Ref]

References

1. Product Information. Pamine Forte (methscopolamine). PharmaDerm. 2006.

2. Product Information. Methscopolamine Bromide (methscopolamine). Boca Pharmacal Inc. 2017.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.